Asthma Control Evaluation (ACE): A Biomarker-Based Approach to Improving Asthma Control and Mechanistic Studies (ICAC-02)

The purpose of ICAC-01 is to determine whether an asthma treatment strategy that measures exhaled nitric oxide (eNO) to indicate disease progression is more effective in treating asthma symptoms when combined with existing asthma treatment guidelines than treatment using the guidelines alone.

ICAC-01数据集的研究目的为：验证通过检测呼出气一氧化氮（exhaled nitric oxide, eNO）评估疾病进展的哮喘治疗策略联合现有哮喘诊疗指南后，在改善哮喘症状方面是否优于单纯采用现有哮喘诊疗指南的治疗方案。